title: [Sclerochoroidal calcifications with vision-threatening choroidal neovascularisation].
abstract: BACKGROUND
  Sclerochoroidal calcification is an uncommon ocular condition in elderly patients. The lesions are frequently bilateral and located at the superotemporal quadrant. The diagnosis is made by fundoscopic appearance, angiography and echography.
  
  
  METHODS
  A 75-year-old man was referred with bilateral choroidal lesions and visual deterioration in the right eye. Examination revealed apart from old signs of a multifocal choroiditis also bilateral, elevated, yellow lesions located at the upper temporal arcades. In the right eye one lesion was accompanied by hemorrhages, edema and lipid exudates. A subsequent fluorescein angiography disclosed choroidal neovascularisation. Ultrasonography showed the characteristic findings of highly reflective lesions with acoustic shadowing. Serum calcium and phosphate levels were normal.
  
  
  RESULTS
  Because of rapid visual deterioration on the right eye Ranibizumab (Lucentis) was injected intravitreal.
  
  
  CONCLUSIONS
  Despite their good prognosis, sclerochoroidal calcifications associated with neovascular membranes can become a vision-threatening disorder.
authors.affiliation: Augenklinik, Kantonsspital Luzern, Luzern, Schweiz. wasiliki.dedes@ksl.ch
authors.forename: W
authors.initials: W
authors.lastname: Dedes
authors.forename: M K
authors.initials: MK
authors.lastname: Schmid
authors.forename: C
authors.initials: C
authors.lastname: Becht
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D002114:Calcinosis / Q000150:complications / Q000188:drug therapy*; D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000069579:Ranibizumab; D015422:Scleral Diseases / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014786:Vision Disorders / Q000209:etiology / Q000517:prevention & control*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab